MedPath

Nutritional Interventions in Patients With Alcohol-associated Hepatitis

Not Applicable
Not yet recruiting
Conditions
Alcoholic Hepatitis
Interventions
Dietary Supplement: Nutritional supplement
Registration Number
NCT06131177
Lead Sponsor
Western University, Canada
Brief Summary

Alcohol-associated hepatitis (AH) is a life-threatening condition with high 90-days mortality (up to 40%) and limited treatment options. Previous studies have shown that decreased nutritional intake (less than 21 kcal/kg/day) is associated to a higher mortality compared to patients with a higher caloric intake. Additionally, it has been suggested that subjects with severe AH, should receive a high-protein diet, however, no specific trials have been carried out to address these questions. Thus, the investigators aim to compare nutritional interventions through a randomized controlled trial to assess if a strategy of peripheral parental nutrition (PPN) plus oral nutritional supplementation (ONS) improves outcomes in patients with severe AH. The investigators will compare standard oral intake, enhanced oral intake with IV fluid supplementation, and PPN plus ONS in patients admitted to hospital with severe AH. These results potentially will help guide practitioners on caloric benchmarks targets for patients with severe AH. This study will also assess specific risks and benefits of different nutritional interventions.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
2000
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TreatmentNutritional supplementPatients are treated with supplementary protein drink
Primary Outcome Measures
NameTimeMethod
Transplant free survival (30 days)30 days

30 days mortality (%)

Secondary Outcome Measures
NameTimeMethod
Transplant free survival (90 days)90 days

90 day mortality (%)

© Copyright 2025. All Rights Reserved by MedPath